IP Library › Granted Patent US 10,898,503
Granted Patent B2
US 10,898,503 · App. 14/986,620 · Granted Jan 26, 2021

Cleavable drug conjugates, compositions thereof and methods of use

Inventor: Mark Quang Nguyen (San Jose, CA)
Assignee: Mark Quang Nguyen
A61K31/7056A61K31/136A61K31/4025A61K31/427A61K31/4745A61K31/519A61K31/704A61K45/06A61K47/545A61K47/549A61K47/60A61K47/64A61K47/643A61K47/6815
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,503
App. No.
14/986,620
Granted
Jan 26, 2021
Kind
B2
Abstract

Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.

Claims (3)

1. A compound is selected from Formula (III-a), Formula (III-b), Formula (III-c), Formula (III-d), Formula (III-e), Formula (III-f), Formula (III-g), Formula (III-h), Formula (III-i), Formula (III-j), Formula (III-k), Formula (III-l), Formula (III-m), Formula (III-n), Formula (III-o), Formula (III-p), Formula (III-q), Formula (III-r), Formula (III-s), Formula (III-t), Formula (III-u), Formula (III-v), Formula (III-w), Formula (III-x), Formula (III-y), Formula (III-z), Formula (III-aa), Formula (III-ab), and Formula (III-ac), or a pharmaceutically acceptable salt of any of the foregoing:

2. A pharmaceutical composition comprising a pharmaceutically acceptable vehicle and at least one compound of claim 1 .

3. The pharmaceutical composition of claim 2 , comprising a therapeutically effective amount of the at least one compound of claim 1 .

Continuity (2)
Division 13854296 · Apr 1, 2013
Related Publication 20160129027A1 · May 12, 2016